Q3 2023 · 13F-HR
Column Group LLCholdings as filed
Filed 2023-11-13 · accession 0000950123-23-010234
$150.6M
Reported value
7
Positions
2023-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 75382E109 | — | RAPT Therapeutics Inc | $44.6M | 29.6% | 2,680,621 | Common | SOLE |
| 76155X100 | RVMD | Revolution Medicines Inc | $34.1M | 22.6% | 1,230,641 | Common | SOLE |
| 87990A106 | TNYA | Tenaya Therapeutics, Inc. | $24.0M | 15.9% | 9,400,290 | Common | SOLE |
| 68622P109 | ORIC | ORIC Pharmaceuticals Inc. | $21.6M | 14.3% | 3,568,181 | Common | SOLE |
| 62921N105 | NGMUSD | NGM Biopharmaceuticals Inc | $19.4M | 12.9% | 18,136,735 | Common | SOLE |
| 86889P109 | — | Surrozen, Inc. | $4.6M | 3.06% | 9,414,795 | Common | SOLE |
| 28202V108 | — | eFFECTOR Therapeutics Inc | $2.4M | 1.60% | 4,026,224 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.